stockrow
Friday 6 November 2026
Export BLTE’s income statement to Excel — free account
Belite Bio, Inc. Sponsored ADR
BLTE Healthcare Biotechnology
- EPS
- −40.0%
- Free cash flow
- +64.7%
Quarter to June 2026, against a year earlier
154.46
11.27
+7.87%
Follow BLTE
Alert me
Belite Bio, Inc. Sponsored ADR (BLTE) Current ratio
Belite Bio, Inc. Sponsored ADR's current ratio at the end of the quarter to 30 June 2026 was 33.6×, down 16.5× from fiscal 2025 (50.0×). Over the past ten years it has ranged from 10.7× (fiscal 2021) to 50.0× (fiscal 2025) — the current reading is the highest in ten years. That is above the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 50.0× | 105.75% |
| FY2024 | 24.3× | (1.80%) |
| FY2023 | 24.8× | 21.68% |
| FY2022 | 20.3× | 90.84% |
| FY2021 | 10.7× | (59.63%) |
| FY2020 | 26.4× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 33.6× | (0.43%) |
| Mar 2026 | 33.7× | (31.33%) |
| Dec 2025 | 49.1× | 42.82% |
| Sep 2025 | 34.4× | 48.47% |
| 14 more quarters | Free account |
Against its own ten years
Low 10.7×
High 50.0×
Ten-year median
24.5×
Current reading's percentile
100
Current ratio against peers
| Company | Current ratio |
|---|---|
| ORKA Oruka Therapeutics, Inc. compare | 38.5× |
| BLTE Belite Bio, Inc. Sponsored ADR | 33.6× |
| CGON CG Oncology, Inc. compare | 22.2× |
| IONS Ionis Pharmaceuticals, Inc. compare | 7.9× |
| IMVT Immunovant, Inc. compare | 7.3× |
| PTCT PTC Therapeutics, Inc. compare | 3.3× |
| KOD Kodiak Sciences Inc. compare | 2.5× |
| MIRM Mirum Pharmaceuticals, Inc. compare | 2.1× |
| LGND Ligand Pharmaceuticals Incorporated compare | 1.2× |
| Biotechnology industry median | 4.9× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)